Publications
Résultats trouvés 145
Auteur Titre Type [ Année
Filtres: First Letter Of Last Name is C [Réinitialiser les filtres]
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.. J Geriatr Oncol. 13(6):850-855.
.
2022. Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.. J Geriatr Oncol. 13(6):850-855.
.
2022. Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.. J Geriatr Oncol. 13(6):850-855.
.
2022. Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer.. J Geriatr Oncol. 13(6):850-855.
.
2022. CARE frailty e-health scale: Association with incident adverse health outcomes and comparison with the Cardiovascular Health Study frailty scale in the NuAge cohort.. Maturitas. 162:37-43.
.
2022. COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.. Gerontology. :1-9.
.
2022. COVID-19 pandemic and mortality in nursing homes across USA and Europe up to October 2021.. Eur Geriatr Med. 13(3):705-709.
.
2022. The effect of different dual tasks conditions on gait kinematics and spatio-temporal walking parameters in older adults.. Gait Posture. 95:63-69.
.
2022. Functional status in older patients with lung cancer: an observational cohort study.. Support Care Cancer. 30(5):3817-3827.
.
2022. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.. PLoS Med. 19(5):e1003999.
.
2022. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.. PLoS Med. 19(5):e1003999.
.
2022. High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.. PLoS Med. 19(5):e1003999.
.
2022. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.. Clin Transl Radiat Oncol. 35:104-109.
.
2022. HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial.. BMC Cancer. 22(1):78.
.
2022. How fiber dynamics of plantarflexor and dorsiflexor muscles based on EMG-driven approach can explain the metabolic cost at different gait speeds.. Eur J Appl Physiol. 122(3):745-755.
.
2022. Immediate voluntary activation deficits following submaximal eccentric contractions of knee extensors are associated with alterations of the sense of movement.. Sci Rep. 12(1):2338.
.
2022. Immediate voluntary activation deficits following submaximal eccentric contractions of knee extensors are associated with alterations of the sense of movement.. Sci Rep. 12(1):2338.
.
2022. Irradiation of localized prostate cancer in the elderly: A systematic literature review.. Clin Transl Radiat Oncol. 35:1-8.
.
2022. Metabolic cost and co-contraction during walking at different speeds in young and old adults.. Gait Posture. 91:111-116.
.
2022. A pragmatic trial testing a tailored non pharmacologic therapies on nocturnal behavioral and psychological symptoms associated with dementia.. Geriatr Nurs. 43:85-90.
.
2022. [Rethinking the management of elderly cancer patients : Proposals from the Age Cancer Priorities French Group].. Bull Cancer. 109(6):714-721.
.
2022. [Rethinking the management of elderly cancer patients : Proposals from the Age Cancer Priorities French Group].. Bull Cancer. 109(6):714-721.
.
2022. Smart Eyeglasses: A Valid and Reliable Device to Assess Spatiotemporal Parameters during Gait.. Sensors (Basel). 22(3)
.
2022. Smart Eyeglasses: A Valid and Reliable Device to Assess Spatiotemporal Parameters during Gait.. Sensors (Basel). 22(3)
.
2022. Smart Eyeglasses: A Valid and Reliable Device to Assess Spatiotemporal Parameters during Gait.. Sensors (Basel). 22(3)
.
2022.